De-prescribing Program to Evaluate Falls in Older Adults

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Opioid-Related DisordersBenzodiazepine-Related DisordersFalls Injury
Interventions
OTHER

Educational Intervention

The intervention has the following components: 1) alerts given to providers to identify patients taking opioids or benzodiazepines (BZD) and therefore at risk for falls; 2) educational materials to inform providers on best practices for de-prescribing opioids and BZDs in patients at risk; and 3) recommendations on de-prescribing provided by a consultant pharmacist. Impact of the intervention will be evaluated using pre-post surveys evaluating changes in providers' knowledge, confidence, and skills as well as information from the EHR to evaluate impact of the intervention on de-prescribing opioids and BZDs.

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

University of North Carolina, Chapel Hill

OTHER

NCT04272671 - De-prescribing Program to Evaluate Falls in Older Adults | Biotech Hunter | Biotech Hunter